ERIK DOMINGUES, Erik Domingues, MD FAAD

Dr. Erik Domingues, a board-certified dermatologist, is Assistant Professor in the Department of Dermatology at UMass Chan Medical School, serving as a medical student preceptor, lecturer, and Dermatology clerkship site director. He is the founder and CEO of Modern Dermatology of Massachusetts in Fall River, MA.
He is nationally recognized for his expertise in vitiligo, atopic dermatitis, psoriasis, and alopecia areata, publishing and lecturing extensively on these topics.
Dr. Domingues is also co-host of "Business Unblemished," a new ongoing business focused-video series sponsored by Dermsquared, where he discusses the business-related topics for running an efficient Dermatology practice with practice owners and thought leaders. He has also provided physician and business owner insights, lecturing at the Annual Dermsquared Practice Access Management Summit.
He volunteers extensively in his community including serving as chairman of the Southcoast Community Foundation Scholarship Committee and previously as a board member. Since 2009, he has volunteered for the American Academy of Dermatology's Camp Discovery in Pennsylvania where he currently serves as co-director of activities.
Financial relationships
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:AbbvieTopic:vitiligoDate added:05/11/2026Date updated:05/11/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:AbbvieTopic:vitiligoDate added:05/11/2026Date updated:05/11/2026
-
Attribution:SelfType of financial relationship:ConsultantIneligible company:ArcutisTopic:psoriasis, AD, seborrheic dermatitisDate added:05/11/2026Date updated:05/11/2026
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:ArcutisTopic:psoriasis, AD, seborrheic dermatitisDate added:05/11/2026Date updated:05/11/2026
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:BMSTopic:psoriasisDate added:05/11/2026Date updated:05/11/2026Relationship end date:10/01/2025
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:BMSTopic:psoriasisDate added:05/11/2026Date updated:05/11/2026Relationship end date:10/01/2025
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:Castle BiosciencesTopic:DecisiondxDate added:05/11/2026Date updated:05/11/2026
-
Attribution:SelfType of financial relationship:AdvisorIneligible company:IncyteTopic:vitiligo, atopic dermatitisDate added:05/11/2026Date updated:05/11/2026
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:IncyteTopic:vitiligo, atopic dermatitisDate added:05/11/2026Date updated:05/11/2026
-
Attribution:SelfType of financial relationship:SpeakerIneligible company:GaldermaTopic:atopic dermatitis, prurigo nodularisDate added:05/11/2026Date updated:05/11/2026

Facebook
X
LinkedIn
Forward